A Phase II Study of Capecitabine, Oxaliplatin, and Cetuximab with or Without Bevacizumab as Frontline Therapy for Metastatic Colorectal Cancer. A Fox Chase Extramural Research Study

OBJECTIVES: Dual inhibition of vascular endothelial growth factor (VEGF) and epidermal growth factor receptor (EGFR) demonstrated initial promise in clinical trials. This phase II study tested the efficacy and safety of capecitabine, oxaliplatin, and cetuximab with or without bevacizumab as first-li...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Dotan, Efrat, Meropol, Neal J., Burtness, Barbara, Denlinger, Crystal S., Lee, James, Mintzer, David, Zhu, Fang, Ruth, Karen, Tuttle, Holly, Sylvester, Judi, Cohen, Steven J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3400721/
https://ncbi.nlm.nih.gov/pubmed/22294255
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12029-012-9368-3
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados